The 10 Companies Booming in Healthcare Sector

Ÿ
Ÿ
Ÿ
Ÿ
Performance Passion – According to Novotech, an
attitude of making it happen drives a dedicated focus
on engagement, quality, accountability, and
performance results
Open Engagement – Novotech’s style of working
recognizes the value of everyone involved
Uncompromised Integrity – It follows the belief that
one should never to hesitate to say or do the right
thing
Unlocking Talent - Novotech seeks and nurtures
people with exceptional talent
Novotech’s Take on Latest Developments
Novotech believes that clinical data quality is considered
the key priority for 2019. According to a recent survey
conducted by J.P. Morgan amongst life sciences’
investors this is especially true given the increasing
complexity of trials and trial designs.
Novotech has driven an increasing investment in upfront
clinical development strategy, including the use of
carefully designed protocols. These include multi-arm,
multi-stage designs with adaptive randomization.
According to Novotech, an efficient approach to clinical
trial design will have the greatest impact in containing
the escalating cost of drug development. It also believes
that the effectiveness of clinical trials also relies on the
selection of the right investigators and excellence in
CRO study management. The company, therefore,
invests heavily in building formal partnerships with
major hospitals and medical specialist sites through
formal site partnership agreements, as well as site
management services which facilitate rapid start-up
activities and patient recruitment to meet the sponsor’s
goals.
Bringing in More for a Better Tomorrow
With biotech companies investing in more complex and
global programs, Novotech sees that biotech sponsors
are increasingly considering locations outside of the US
for their trials, such as Eastern Europe and Asia-Pacific.
The company’s clinical staff numbers have grown by
more than 20% in Asia over the last quarter of 2018 and
50% over the last twelve months. This growth in the
number of staff members is fuelled by demand for a
regional CRO with international accreditation and
reputation, combined with local knowledge,
partnerships, and expertise in the region. Furthermore,
the company’s initiative of integration of capabilities,
such as BioDesk, will bring tremendous support to
biotech companies looking for global regulatory
services.